UMIN000050583Recruiting
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes -retrospective observation trial
Hokkaido University HospitalPhase 4University Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Type 2 diabetes
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Hokkaido University Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- Phase 4
- Start date
- Oct 19, 2022
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000050583
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000050583 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hokkaido University Hospital and is currently Recruiting. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.